Analystreport

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Barclays PLC from $509.00 to $418.00. They now have an "equal weight" rating on the stock.

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com